Clinical Trials in Boston

Showing 901-920 of 8,503 trials

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

NCT04921787

This study is a multi-site, cluster randomized, two group implementation trial comparing a low- versus high-intensity implementation strategy for supporting hospital-based opioid use disorder treatment (HBOT) in community hospital settings where medication for opioid use disorder (MOUD) treatment has not been implemented.

Substance Use DisordersOpioid Use Disorder, SevereOpioid Use Disorder, Moderate

Gavin Bart24 participantsStarted Oct 2021

Boston, Massachusetts, United States • Minneapolis, Minnesota, United States • New York, New York, United States +1 more locations

TERMINATEDPHASE2< 1 mile

A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA

NCT05462990

The purpose of the study was to find out if the investigational treatment named QUC398 had beneficial effects on osteoarthritis (OA) knee pain and knee cartilage, and if it was safe and tolerated.

Osteoarthritis, Knee

Novartis Pharmaceuticals101 participantsStarted Nov 2022

Tampa, Florida, United States • Boston, Massachusetts, United States • Morehead City, North Carolina, United States +11 more locations

EXHIT ENTRE Implementation Trial of High Intensity Versus Low Intensity Strategy

A Proof-of-concept Study to Examine QUC398 in Participants With Knee OA

Find Trials by Condition in Boston

Efficacy and Safety of Tezepelumab in Participants With Severe Chronic Rhinosinusitis With Nasal Polyposis

Gene Replacement Therapy Clinical Trial for Participants With Spinal Muscular Atrophy Type 1

A Study of Galcanezumab (LY2951742) in Participants 6 to 17 Years of Age With Episodic Migraine

Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients With Stage II-III Colorectal Cancer

Study to Evaluate the Efficacy, Immunogenicity, and Safety of RSVpreF in Adults.

PIONEER III Trial to Assess Safety and Efficacy of the BuMA Supreme™ Drug Coated Coronary Stent in Patients With Coronary Disease

A 12-week Study to Assess the Efficacy and Safety of Budesonide and Formoterol Fumarate Metered Dose Inhaler Relative to Budesonide Metered Dose Inhaler in Participants With Inadequately Controlled Asthma (LITHOS)

Single Fraction Stereotactic Radiosurgery Compared With Fractionated Stereotactic Radiosurgery in Treating Patients With Resected Metastatic Brain Disease

A Study to Compare ABP 234 and Keytruda® (Pembrolizumab) in Participants With Advanced or Metastatic Non-squamous Non-Small Cell Lung Cancer

This Study Tests the New Medicine BI 754111 Alone or in Combination With Another New Substance BI 754091 in Patients With Advanced Cancer. The Study Tests Different Doses to Find the Best Dose for Continuous Treatment.

Registry of Avance® Nerve Graft's Utilization and Recovery Outcomes Post Peripheral Nerve Reconstruction

First-in-Human Study of ADCE-D01 in Soft Tissue Sarcoma

A Study of TAK-330 to Reverse the Effects of Factor Xa Inhibitors For Adults Needing Urgent Surgery

A Study to Learn More About How Well BAY3018250 Works and How Safe it is for People With Proximal Deep Vein Thrombosis

BOLD-100 in Combination With FOLFOX for the Treatment of Advanced Solid Tumours

A Proof of Concept and Dose-finding Study of XXB750 in Patients With Heart Failure

LSALT Peptide for Prevention or Attenuation of Acute Kidney Injury (AKI) in Patients Undergoing On-Pump Cardiac Surgery

Gevokizumab With Standard of Care Anti-cancer Therapies for Metastatic Colorectal, Gastroesophageal, and Renal Cancers